NANOVIRICIDES, INC. Derivative Liability, Noncurrent
NANOVIRICIDES, INC. (NNVC) had Derivative Liability, Noncurrent of $1.59 million as of 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2019-05-15
- 2019-03-31: Derivative Liability, Noncurrent $1.59M.
- 2018-06-30: Derivative Liability, Noncurrent $0.00.
- 2014-09-30: Derivative Liability, Noncurrent $3.79M.
- 2014-06-30: Derivative Liability, Noncurrent $5.70M.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2019-03-31 | $1.59M 10-Q · filed 2019-05-15 |
| 2018-06-30 | $0.00 10-Q · filed 2019-05-15 |
| 2014-09-30 | $3.79M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $5.70M 10-K · filed 2015-02-23 |
| 2014-03-31 | $3.82M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $7.58M 10-Q · filed 2014-02-14 |
| 2013-09-30 | $7.89M 10-Q/A · filed 2015-02-23 |
| 2013-06-30 | $3.75M 10-K · filed 2015-02-23 |
| 2012-06-30 | $0.00 10-K/A · filed 2013-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |